Menu
Recruiting NCT06535243

Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder

No phase Interventional Post-Traumatic Stress Disorder Complex Psychiatric Disorder Abuse Neglect Abuse Physical

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Lifespan Integration Therapy (LI).
Who it may be relevant to
Registry conditions: Post-Traumatic Stress Disorder Complex, Psychiatric Disorder, Abuse Neglect, Abuse Physical. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of the Efficacy of "Lifespan Integration" Therapy in Patients With Complex Post-Traumatic Stress Disorder

Overview

The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD

Interventions

  • Behavioral Lifespan Integration Therapy (LI)
    same as above

Primary outcome measures

  • change of the scores of International Trauma Questionnaire [Time frame: maximum one year]
Secondary outcome measures (1)
  • Difficulties in Emotion Regulation Scale (DERS) Score [Time frame: maximum one year]

Eligibility criteria

Inclusion criteria

  • patients diagnosed with complex PTSD
  • French speaking
  • first time following an LI type of therapy
  • psychotropic treatment is allowed

Exclusion criteria

  • no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a "wash out " period of minimum 4 weeks is required )
  • no active manic episode at the time of inclusion
  • no active psychotic episode at the time of inclusion
  • no chronic psychotic disorder diagnosis
  • no autistic spectrum disorder diagnosis ,
  • no intellectual deficit

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • CHU St Anne — Paris

Identifiers

NCT: NCT06535243 · D21-P019

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗